Literature DB >> 19933155

TNFalpha shedding and epidermal inflammation are controlled by Jun proteins.

Juan Guinea-Viniegra1, Rainer Zenz, Harald Scheuch, Denes Hnisz, Martin Holcmann, Latifa Bakiri, Helia B Schonthaler, Maria Sibilia, Erwin F Wagner.   

Abstract

Inducible epidermal deletion of JunB and c-Jun in adult mice causes a psoriasis-like inflammatory skin disease. Increased levels of the proinflammatory cytokine TNFalpha play a major role in this phenotype. Here we define the underlying molecular mechanism using genetic mouse models. We show that Jun proteins control TNFalpha shedding in the epidermis by direct transcriptional activation of tissue inhibitor of metalloproteinase-3 (TIMP-3), an inhibitor of the TNFalpha-converting enzyme (TACE). TIMP-3 is down-regulated and TACE activity is specifically increased, leading to massive, cell-autonomous TNFalpha shedding upon loss of both JunB and c-Jun. Consequently, a prominent TNFalpha-dependent cytokine cascade is initiated in the epidermis, inducing severe skin inflammation and perinatal death of newborns from exhaustion of energy reservoirs such as glycogen and lipids. Importantly, this metabolic "cachectic" phenotype can be genetically rescued in a TNFR1-deficient background or by epidermis-specific re-expression of TIMP-3. These findings reveal that Jun proteins are essential physiological regulators of TNFalpha shedding by controlling the TIMP-3/TACE pathway. This novel mechanism describing how Jun proteins control skin inflammation offers potential targets for the treatment of skin pathologies associated with increased TNFalpha levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19933155      PMCID: PMC2779759          DOI: 10.1101/gad.543109

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  50 in total

Review 1.  Sic transit gloria: farewell to the epidermal transit amplifying cell?

Authors:  Philip H Jones; Benjamin D Simons; Fiona M Watt
Journal:  Cell Stem Cell       Date:  2007-10-11       Impact factor: 24.633

2.  Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha.

Authors:  M L Moss; S L Jin; M E Milla; D M Bickett; W Burkhart; H L Carter; W J Chen; W C Clay; J R Didsbury; D Hassler; C R Hoffman; T A Kost; M H Lambert; M A Leesnitzer; P McCauley; G McGeehan; J Mitchell; M Moyer; G Pahel; W Rocque; L K Overton; F Schoenen; T Seaton; J L Su; J D Becherer
Journal:  Nature       Date:  1997-02-20       Impact factor: 49.962

3.  A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.

Authors:  R A Black; C T Rauch; C J Kozlosky; J J Peschon; J L Slack; M F Wolfson; B J Castner; K L Stocking; P Reddy; S Srinivasan; N Nelson; N Boiani; K A Schooley; M Gerhart; R Davis; J N Fitzner; R S Johnson; R J Paxton; C J March; D P Cerretti
Journal:  Nature       Date:  1997-02-20       Impact factor: 49.962

Review 4.  Through thick and thin: wasting, obesity, and TNF alpha.

Authors:  B M Spiegelman; G S Hotamisligil
Journal:  Cell       Date:  1993-05-21       Impact factor: 41.582

5.  WEHI-13VAR: a stable and sensitive variant of WEHI 164 clone 13 fibrosarcoma for tumor necrosis factor bioassay.

Authors:  K S Khabar; S Siddiqui; J A Armstrong
Journal:  Immunol Lett       Date:  1995-05       Impact factor: 3.685

6.  Severe cachexia in mice inoculated with interferon-gamma-producing tumor cells.

Authors:  P Matthys; R Dijkmans; P Proost; J Van Damme; H Heremans; H Sobis; A Billiau
Journal:  Int J Cancer       Date:  1991-08-19       Impact factor: 7.396

7.  Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes.

Authors:  J Rothe; W Lesslauer; H Lötscher; Y Lang; P Koebel; F Köntgen; A Althage; R Zinkernagel; M Steinmetz; H Bluethmann
Journal:  Nature       Date:  1993-08-26       Impact factor: 49.962

8.  Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice.

Authors:  J Cheng; K Turksen; Q C Yu; H Schreiber; M Teng; E Fuchs
Journal:  Genes Dev       Date:  1992-08       Impact factor: 11.361

9.  Identity of tumour necrosis factor and the macrophage-secreted factor cachectin.

Authors:  B Beutler; D Greenwald; J D Hulmes; M Chang; Y C Pan; J Mathison; R Ulevitch; A Cerami
Journal:  Nature       Date:  1985 Aug 8-14       Impact factor: 49.962

10.  Inhibition of tumor necrosis factor (TNF)-mediated NF-kappa B activation by selective blockade of the human 55-kDa TNF receptor.

Authors:  G Kruppa; B Thoma; T Machleidt; K Wiegmann; M Krönke
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

View more
  32 in total

1.  Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ADAM17.

Authors:  Juan Guinea-Viniegra; Rainer Zenz; Harald Scheuch; María Jiménez; Latifa Bakiri; Peter Petzelbauer; Erwin F Wagner
Journal:  J Clin Invest       Date:  2012-07-09       Impact factor: 14.808

Review 2.  Psoriasis: what we have learned from mouse models.

Authors:  Erwin F Wagner; Helia B Schonthaler; Juan Guinea-Viniegra; Erwin Tschachler
Journal:  Nat Rev Rheumatol       Date:  2010-09-28       Impact factor: 20.543

Review 3.  Metalloproteinases and their natural inhibitors in inflammation and immunity.

Authors:  Rama Khokha; Aditya Murthy; Ashley Weiss
Journal:  Nat Rev Immunol       Date:  2013-09       Impact factor: 53.106

4.  JUNB/AP-1 controls IFN-γ during inflammatory liver disease.

Authors:  Martin K Thomsen; Latifa Bakiri; Sebastian C Hasenfuss; Rainer Hamacher; Lola Martinez; Erwin F Wagner
Journal:  J Clin Invest       Date:  2013-11-08       Impact factor: 14.808

5.  Regulation of oxidative stress by methylation-controlled J protein controls macrophage responses to inflammatory insults.

Authors:  Nicolás Navasa; Itziar Martín; Juan Manuel Iglesias-Pedraz; Naiara Beraza; Estíbaliz Atondo; Hooman Izadi; Furkan Ayaz; Sara Fernández-Álvarez; Ketki Hatle; Abhigyam Som; Oliver Dienz; Barbara A Osborne; Maria Luz Martínez-Chantar; Mercedes Rincón; Juan Anguita
Journal:  J Infect Dis       Date:  2014-07-14       Impact factor: 5.226

Review 6.  ADAM-17: the enzyme that does it all.

Authors:  Monika Gooz
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-04       Impact factor: 8.250

7.  Targeted deletion of Jun/AP-1 in alveolar epithelial cells causes progressive emphysema and worsens cigarette smoke-induced lung inflammation.

Authors:  Narsa M Reddy; Suryanaraya Vegiraju; Ashley Irving; Bogdan C Paun; Irina G Luzina; Sergei P Atamas; Shyam Biswal; Navas-Acien Ana; Wayne Mitzner; Sekhar P Reddy
Journal:  Am J Pathol       Date:  2012-02       Impact factor: 4.307

Review 8.  Cell-extracellular matrix interactions in normal and diseased skin.

Authors:  Fiona M Watt; Hironobu Fujiwara
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-04-01       Impact factor: 10.005

9.  Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis.

Authors:  Helia B Schonthaler; Reto Huggenberger; Stefanie K Wculek; Michael Detmar; Erwin F Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-07       Impact factor: 11.205

10.  IGFBP-3 inhibits TNF-α production and TNFR-2 signaling to protect against retinal endothelial cell apoptosis.

Authors:  Qiuhua Zhang; Jena J Steinle
Journal:  Microvasc Res       Date:  2014-07-30       Impact factor: 3.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.